Adiponectin Receptor Agonist Effectively Suppresses Hepatocellular Carcinoma Growth
Authors:
- 20 January 2024
- journal article
- research article
- Published by Springer Nature in Cell Biochemistry and Biophysics
- Vol. 82 (2) , 687-695
Abstract
Hepatocellular carcinoma (HCC) is the second lethal cancer. Short overall survival, low five-year survival rate, and unimproved treatment efficacy urge the need to improve HCC prognosis. Adiponectin is key protector against cancer and hepatic abnormalities. Hypoadiponectinemia occurs in and promotes carcinogenesis and hepatic diseases. Adiponectin reactivation by different methods showed impressive effect against cancer and hepatic diseases. Recently, AdipoRon, an adiponectin receptor agonist, can interact with both Adiponectin receptors. AdipoRon showed promising anti-cancer effect in some cancers, but no study on HCC yet. The in vitro effect of AdipoRon on HCC was investigated by cell viability, migration, invasion, colony formation and apoptosis assays. The signalling alteration was determined by RT-qPCR and Western blot. The effect of treatment was interpreted by comparison between treatments and control. The difference between two cell lines was relatively compared. Our results showed significant in vitro anti-cancer effect of AdipoRon via AMPK- and dose-dependent manner. Huh7 cells showed a lower level of AdipoR1/2 and a superior proliferation and aggressiveness, compared to Hep3B. In addition, Huh7 cells were more sensitive to AdipoRon treatment (lower IC50, less cell growth, migration, invasion and colonies upon AdipoRon treatment) than Hep3B cells. In conclusion, AdipoRon effectively inhibited HCC growth and invasiveness in vitro. The deficient expression of adiponectin receptors affects efficacy of AdipoRon and aggressiveness of HCC cells.Keywords
This publication has 42 references indexed in Scilit:
- Adiponectin Pathway Attenuates Malignant Mesothelioma Cell GrowthAmerican Journal of Respiratory Cell and Molecular Biology, 2012
- Adiponectin Modulates C-Jun N-Terminal Kinase and Mammalian Target of Rapamycin and Inhibits Hepatocellular CarcinomaGastroenterology, 2010
- Adiponectin suppresses colorectal carcinogenesis under the high-fat diet conditionGut, 2008
- Growth-inhibitory effect of adiponectin via adiponectin receptor 1 on human breast cancer cells through inhibition of S-phase entry without inducing apoptosisBreast Cancer Research and Treatment, 2007
- Hypoadiponectinemia accelerates hepatic tumor formation in a nonalcoholic steatohepatitis mouse modelJournal of Hepatology, 2007
- Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actionsNature Medicine, 2007
- Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndromeJournal of Clinical Investigation, 2006
- Adiponectin and cancer: a systematic reviewBritish Journal of Cancer, 2006
- AMP-Activated Protein Kinase Signaling Stimulates VEGF Expression and Angiogenesis in Skeletal MuscleCirculation Research, 2005
- Cloning of adiponectin receptors that mediate antidiabetic metabolic effectsNature, 2003